RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BIMBATTI D
Collezione AOU Novara

Items : 3

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients. in Therapeutic advances in urology / Ther Adv Urol. 2024 Apr 17;16:17562872241244574. doi: 10.1177/17562872241244574. eCollection 2024 Ja

2024
AOU Novara

Buti S; Olivari A; Masini C; Bimbatti D; Sartori D; Ermacora P; Cattrini C; Vitale MG; Rossi E; Mucciarini C; Rizzo M; Sisani M; Santoni M; Roviello G; Mollica V; Conteduca V; Grillone F; Cinausero M; Prati G; Atzori F; Stellato M; Massari F; Bersanelli M;

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? in European urology oncology / Eur Urol Oncol. 2024 Feb;7(1):102-111. doi: 10.1016/j.euo.2023.07.003. Epub 2023 Jul 21.

2024
AOU Novara

Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; et alii...

Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25). in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Aug;22(4):102099. doi: 10.1016/j.clgc.2024.102099. Epub 2024 Apr 24.

2024
AOU Novara

Gambale E; Maruzzo M; Messina C; De Gennaro Aquino I; Vascotto IA; Rossi V; Bimbatti D; Cavasin N; Messina M; Mennitto A; Rebuzzi SE; Nasso C; Mercinelli C; Maiorano BA; Fanelli M; Sorarù M; Scolari F; Mela MM; Galli L; Salfi A; Rizzo M; Puglisi S; Orlando V; Fornarini G; Rametta A; Giannatempo P; Cerbone L; Doni L; Roviello G; et alii...